A pioneer in its field, Echosens significantly changed the practice of liver diagnosis with FibroScan®, the non-invasive gold standard solution for comprehensive management of liver health. FibroScan® is recognized worldwide as the reference for liver fibrosis and liver steatosis assessment with more than 2,500+ peer-reviewed publications and 60+ international guidelines recommendations. Echosens has made FibroScan® available in over 100+ countries enabling millions of liver examinations worldwide.
We are working hand in hand with physicians, medical academic research, pharmaceutical companies for patient identification and monitoring in NAFLD/NASH.
As patient education is a major issue, we have created the “myliverexam” website that provides information about the role of the liver and why it is vital to the global health.
Company’s Keywords:
diagnostic noninvasif en hepatologie, pionnier en elastographie quantitative, evaluation de la fibrose hepatique et de la cirrhose
<230
<79059000
<2001